BCL6 |
B-cell leukemia/lymphoma 6 |
2.408 |
(1.94, 2.88) |
0.00006 |
|
|
|
|
|
|
CCL22 |
Chemokine (C-C motif) ligand 22 |
5.309 |
(2.69, 7.93) |
0.00045 |
5.249 |
(2.83, 7.67) |
0.00022 |
|
|
|
CCL24 |
Chemokine (C-C motif) ligand 24 |
59.800 |
(42.54, 77.06) |
< 0.00001 |
|
|
|
|
|
|
CCL26 |
Chemokine (C-C motif) ligand 26 |
5.396 |
(3.50, 7.29) |
< 0.00001 |
|
|
|
|
|
|
CSF2 |
Colony stimulating factor 2 (granulocyte-macrophage) |
148.914 |
(118.08, 179.74) |
< 0.00001 |
47.615 |
(39.28, 55.95) |
< 0.00001 |
4.018 |
(3.33, 4.70) |
< 0.00001 |
IL4 |
Interleukin 4 |
8.696 |
(6.26, 11.13) |
0.00001 |
12.324 |
(9.57, 15.08) |
< 0.00001 |
3.679 |
(2.41, 4.95) |
0.00038 |
IL12A |
Interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) |
6.789 |
(2.15, 11.43) |
0.00048 |
|
|
|
|
|
|
IL12B |
Interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
5.196 |
(0.00001, 10.54) |
0.03230 |
|
|
|
|
|
|
IL13RA2 |
Interleukin 13 receptor, alpha 2 |
19.244 |
(16.80, 21.69) |
< 0.00001 |
23.779 |
(21.19, 26.37) |
< 0.00001 |
5.049 |
(4.19, 5.91) |
< 0.00001 |
IL17A |
Interleukin 17A |
33.457 |
(21.68, 45.24) |
0.00004 |
35.543 |
(25.63, 45.46) |
< 0.00001 |
7.563 |
(5.64, 9.49) |
< 0.00001 |
IL1RL1 |
Interleukin 1 receptor-like 1 |
180.497 |
(122.94, 238.06) |
< 0.00001 |
161.270 |
(105.45, 217.09) |
< 0.00001 |
7.296 |
(4.95, 9.64) |
< 0.00001 |
PPARG |
Peroxisome proliferator-activated receptor gamma |
5.415 |
(4.81, 6.02) |
< 0.00001 |
7.367 |
(6.40, 8.34) |
< 0.00001 |
3.004 |
(2.63, 3.38) |
< 0.00001 |
PRG2 |
Proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) |
|
|
|
2.600 |
(2.04, 3.16) |
0.00004 |
|
|
|
PTGDR2 |
Prostaglandin D2 receptor 2 |
3.725 |
(1.55, 5.90) |
0.00374 |
|
|
|
|
|
|
TBX21 |
T-box 21 |
28.785 |
(23.31, 34.26) |
< 0.00001 |
|
|
|
|
|
|
TSLP |
Thymic stromal lymphopoietin |
11.999 |
(9.61, 14.39) |
< 0.00001 |
2.602 |
(2.03, 3.18) |
0.00002 |
|
|
|